Clinical management of latex-allergic children

R S Holzman1

  • 1Department of Anesthesiology, Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. Holzman@a1.tch.harvard.edu

Anesthesia and Analgesia
|September 20, 1997
PubMed

Insights

Children with latex allergy undergoing anesthesia can be safely managed using a latex-safe protocol. Prophylactic allergy medications are not necessary, emphasizing avoidance of latex exposure during medical procedures.

Area of Science:

  • Pediatric Anesthesiology
  • Allergy and Immunology

Background:

  • Latex allergy is a recognized concern in children with myelodysplasia and urological anomalies.
  • These children often present with multiple allergies, including medications, foods, and environmental sensitivities.

Purpose of the Study:

  • To evaluate the safety and efficacy of a latex-safe anesthetic protocol in children with known latex allergy.
  • To determine the necessity of allergy chemoprophylaxis in this patient population.

Main Methods:

  • A retrospective audit of 162 children with latex allergy undergoing 267 anesthetics.
  • Anesthesia was administered strictly following a latex-safe protocol.
  • No allergy prophylaxis medications were given pre-operatively.

Main Results:

  • Only one patient (1 of 162) experienced an allergic reaction, unrelated to latex exposure.
  • No other patients exhibited signs or symptoms of allergic reactions during or after anesthesia.
  • The protocol successfully facilitated anesthesia for the majority of patients without adverse events.

Conclusions:

  • Latex-allergic children can undergo anesthesia safely with a rigorously applied latex-safe protocol.
  • Allergy chemoprophylaxis is not required, and avoidance of latex products is paramount.
  • This approach minimizes allergic risks in a vulnerable pediatric population.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...